Robert M. Infarinato
CIK: 0002032518
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PHIO
Phio Pharmaceuticals Corp.
Officer
Discretionary Trading P&L
Holdings
About Infarinato Robert M.
Infarinato Robert M. (SEC CIK 0002032518) files insider reports with the SEC as VP, CFO of Phio Pharmaceuticals Corp. (PHIO).
Signal8 holds 1 ownership filing by Infarinato Robert M., a Form 4, filed on Sep 13, 2024. Those filings report 1 transaction, the latest on Sep 11, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Infarinato Robert M.'s filings is in MARLBOROUGH, MA.
Recent filings by Infarinato Robert M.
- Sep 11, 2024: Grant or award of PHIO shares (Form 4, code A).
Other insiders filing for Phio Pharmaceuticals Corp. (PHIO)
- Carson Lisa Cabott, Chief Financial Officer
- Bitterman Robert J, Chairman, Pres. & CEO
- Plott Ronald Todd, Director
- BRADFORD PATRICIA A, Director
- Lockshin Curtis, Director
- Freeman Jonathan E, Director